2-Bromoethyl methyl ether → 5-(4-fluoro-benzyl)-3-(2-methoxyethyl)-3H-thiazol-2-ylidene-amine

HRID 1469935

Reaktionsgleichung

Reaktionsgleichung von HRID 1469935
[F:1][C:2]1[CH:14]=[CH:13][C:5]([CH2:6][C:7]2[S:11][C:10]([NH2:12])=[N:9][CH:8]=2)=[CH:4][CH:3]=1.[CH3:15][O:16][CH2:17][CH2:18]Br>C(OCC)(=O)C>[F:1][C:2]1[CH:14]=[CH:13][C:5]([CH2:6][C:7]2[S:11][C:10](=[NH:12])[N:9]([CH2:18][CH2:17][O:16][CH3:15])[CH:8]=2)=[CH:4][CH:3]=1

Komponenten

4

Reaktionsbedingungen

Temperatur
85 °C

Versuchsvorschrift

A mixture of 5-(4-fluoro-benzyl)-thiazol-2-ylamine (330 mg, 1.59 mmol) and 2-bromoethyl methyl ether (0.50 mL, 5.34 mmol) was heated to 85° C. and stirred for 12 hours. The mixture was cooled to ambient temperature, diluted with 20 mL of ethyl acetate and washed with saturated aqueous NaHCO3. The layers were separated and the aqueous phase was extracted with 2×20 mL ethyl acetate and the combined organic extracts were dried over anhydrous Na2SO4, filtered, and concentrated. Purification by column chromatography (SiO2, 50% ethyl acetate in dichloromethane containing 0.5% Et3N) afforded 342 mg of the title compound: MS (LC/MS) m/z 267 (M+H)+.

Aufarbeitung

  1. temperatureThe mixture was cooled to ambient temperature
  2. washwashed with saturated aqueous NaHCO3
  3. customThe layers were separated
  4. extractionthe aqueous phase was extracted with 2×20 mL ethyl acetate
  5. dry with materialthe combined organic extracts were dried over anhydrous Na2SO4
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customPurification by column chromatography (SiO2, 50% ethyl acetate in dichloromethane containing 0.5% Et3N)

Quellen und Nachweise

ORD-Eintrag
ord-dab0002979ac42338934b195b845718f
Quelldatensatz
uspto-grants-2015_04
Patentnummer
US09006275B2

Verknüpfte Notizen

Wird geladen…